Properties and usefulness of the original K-562 human myelogenous leukemia cell line

Leukemia Research - Tập 3 Số 6 - Trang 363-370 - 1979
Bismarck B. Lozzio1, Carmen B. Lozzio1
1University of Tennessee, Department of Medical Biology/Memorial Research Center, Laboratories of Experimental Hematology and Oncology (BBL) and Medical Genetics and Tissue Culture (CBL), Knoxville, TE 37920, U.S.A.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Andersson, 1979, Induction of erythroid differentiation in the human leukaemia cell line K562, Nature, Lond., 278, 364, 10.1038/278364a0

Andersson, 1979, K562—A human erythroleukemic cell line, Int. J. Cancer, 23, 143, 10.1002/ijc.2910230202

Bamberger, 1978, Inhibition of human leukemia cell proliferation by dimethyl sulfoxide, Leukemia Res., 2, 305, 10.1016/0145-2126(78)90017-6

Briggs, 1979, Human granulocyte specific chromatin antigens in normal and leukemic cells, 20, 244

Collins, 1977, Characterization of an antigen from the myelogenous leukemic cell line, K-562, J. natn. Cancer Inst., 59, 1667, 10.1093/jnci/59.6.1667

Drew, 1977, Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker, Blood, 49, 715, 10.1182/blood.V49.5.715.715

Haller, 1978, Mouse natural cell-mediated cytotoxicity to human leukemia: independence of serum source used for target-cell culturing and cytotoxicity assay, J. natn. Cancer Inst., 60, 1433, 10.1093/jnci/60.6.1433

Herberman, 1977, Natural cell-mediated cytotoxicity against tumors, 147

Herberman, 1978, Natural cell-mediated immunity, Adv. Cancer Res., 27, 305, 10.1016/S0065-230X(08)60936-7

Huberman, 1979, Induction of terminal differentiation in human myeloid leukemia cells by tumor-promoting agents, 20, 281

Jondal, 1975, Surface markers of human B- and T-lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations, Int. J. Cancer, 15, 596, 10.1002/ijc.2910150409

Koyama, 1977, Alloantigens of human lymphoid cell lines; “human Ia-like antigens”, 33, 217

Latif, 1979, Abrogation of the proliferation of human leukemia cells in nude mice by a xenoantiserum, Leukemia Res., 3, 371, 10.1016/0145-2126(79)90034-1

Latif, 1979, Evaluation of drug-antibody conjugates in the treatment of human myelosarcomas transplanted in nude mice, Cancer

Lozzio, 1976, The Lasat mouse: a new model for transplantation of human tissues, Biomedicine, 24, 144

Lozzio, 1979, Growth and treatment of human myelogenous leukemia in immunodeficient mice

Lozzio, 1977, Virus antigens in the K-562 cells, 19, 136

Lozzio, 1976, Human myelogenous (Ph1+) leukemic cell line: transplantation into athymic mice, J. natn. Cancer Inst., 56, 627, 10.1093/jnci/56.3.627

Lozzio, 1977, Suppression of human myelosarcomas growth in athymic mice by a primate antiserum, Cancer Treat. Rep., 69, 1679

Lozzio, 1979, Reproducible metastatic growth of the K-562 human myelogenous leukemia cells in lasat and nude mice, J. natn. Cancer Inst., 63, 295

Lozzio, 1976, Hereditary asplenic-athymic mice: transplantation of human myelogenous leukemic cells, J. Expt. Med., 143, 225, 10.1084/jem.143.1.225

Lozzio, 1977, Leukemia-associated antigens detected by a nonhuman primate antiserum to a Ph1+ myelogenous leukemia cell line, Blood, 50, 115, 10.1182/blood.V50.1.115.115

Lozzio, 1973, Cytotoxicity of a factor isolated from human spleen, J. natn. Cancer Inst., 50, 535, 10.1093/jnci/50.2.535

Lozzio, 1974, Characterization of a human cell-line with the Philadelphia chromosome, IRCS Journals (Hematol., Immunol., Cancer, 2, 1435

Lozzio, 1975, Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome, Blood, 45, 321, 10.1182/blood.V45.3.321.321

Lozzio, 1978, Correlation of leukemia-associated antigens and the Ph1 chromosome in fibroblast-like cells derived from bone marrow, Blood, 52, 673, 10.1182/blood.V52.4.673.673

Lozzio, 1979, Effects of sodium butyrate on human chronic myelogenous leukaemia cell line K-562, Nature, Lond., 281, 709, 10.1038/281709b0

Lozzio, 1976, Absence of T-derived lymphocyte markers in a myelogenous leukemia (Ph1+) cell line K-562, Cancer Res., 36, 4657

Machado, 1977, Development of myelosarcomas from human myelogenous leukemia cells transplanted in athymic mice, Cancer Res., 37, 3995

Olofsson, 1978, Inhibitor of hematopoietic cell proliferation derived from a human leukemia cell line, Blood, 52, 143, 10.1182/blood.V52.1.143.143

Ortaldo, 1977, Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line, J. natn. Cancer Inst., 59, 77, 10.1093/jnci/59.1.77

Pross, 1977, Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VI. A brief review, Cancer Immunology and Immunotherapy, 3, 75, 10.1007/BF00200062

Pross, 1975, Cytotoxic lymphocytes from normal donors, 21, 226

Pross, 1978, Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. V. The role of serum-derived heterologous membrane antigens, Int. J. Cancer, 21, 291, 10.1002/ijc.2910210307

West, 1977, Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells, J. Immunol., 118, 355, 10.4049/jimmunol.118.1.355

Whitson, 1976, Cytotoxicity of antisera to a myelogenous leukemic cell line with the Philadelphia chromosome, J. natn. Cancer Inst., 56, 903, 10.1093/jnci/56.5.903